Riskpilot← Back to searchSign inGet full accessMax Medical Consultations AB
ABActiveOrg 5569367393Isbergs Gata 12 Lgh 1402General medical practice activities · NACE 8621Est. 20130 employees
Revenue 2024
SEK 0
EBITDA margin
—
+58% vs 2023
Equity ratio
84.2%
Financial strength
Net profit 2024
SEK -7K
+84% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -11K | +58% |
| Net profit | SEK -7K | +84% |
| Total assets | SEK 74K | -65% |
| Equity | SEK 62K | -69% |
| Employees | 0 | — |
Legal name
Max Medical Consultations AB
Org number
5569367393
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
4 juli 2013
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget ska bedriva medicinsk konsultverksamhet.
Address
Isbergs Gata 12 Lgh 1402
Phone
+46709972624
Email
max.sahlinlarsson@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 28 | 0 | 0 |
| Staff expenses | — | — | −0 | — | −1 |
| EBITDA | −28 | −36 | 13 | −26 | −11 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −28 | −36 | 13 | −26 | −11 |
| Net financials | — | 453 | 0 | −17 | 4 |
| Profit before tax | 87 | 442 | 13 | −43 | −7 |
| Tax | −20 | −0 | −1 | — | — |
| Net profit | 67 | 442 | 12 | −43 | −7 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 262 | 529 | 261 | 210 | 74 |
| Equity | 167 | 494 | 242 | 199 | 62 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 71 | 36 | 19 | 11 | 12 |
| Total debt | 71 | 36 | 19 | 11 | 12 |
EBITDA margin
-1070800.0%
This company
15.8%
Market median
-6777315% vs market
20202024
Equity ratio
84.2%
This company
38.2%
Market median
+120% vs market
20202024
Return on equity
-11.2%
This company
18.4%
Market median
-161% vs market
20202024
Net profit margin
-699100.0%
This company
8.1%
Market median
-8630964% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
ML Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (1) | ||
NP Chief Executive Officer | Chief Executive Officer | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2024 | |
| Former (2) | ||
| Deputy Board Member | 2022 – 2024 | |
| Board of Directors | 2023 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Max Medical Consultations AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maximilian Leonard Viking Larsson | Chief Executive Officer | 0 companies |
| Nils Peter Larsson | Chief Executive Officer | 0 companies |
| Carl Fredrik Larsson | Deputy Board Member | 0 companies |
| Annie Freja Hedebark | Board of Directors | 0 companies |
| Tapomita Sahlin Larsson | Deputy Board Member | 0 companies |